SCHEMBL22043348

SCHEMBL22043348

O=C(O)CCC(=O)OCC(O)COCC(O)COCC(O)COC(=O)CCC(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.41
KDM4E B2RXH2 1/20 0.41
DUSP3 P51452 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
LPAR1 Q92633 5/20 0.39
LPAR6 P43657 1/20 0.39
LPAR4 Q99677 1/20 0.39
LPAR5 Q9H1C0 1/20 0.39
LPAR2 Q9HBW0 1/20 0.39
LPAR3 Q9UBY5 1/20 0.39
ENPP2 Q13822 1/20 0.39
EGLN1 Q9GZT9 2/20 0.38
KDM6B O15054 1/20 0.38
KDM5C P41229 1/20 0.38
PHF8 Q9UPP1 1/20 0.38
KDM2A Q9Y2K7 1/20 0.38
ALKBH5 Q6P6C2 1/20 0.38
SUCNR1 Q9BXA5 1/20 0.38
P2RY10 O00398 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26008133 0.93 LMNA (0.51) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL22043577 0.88 LMNA (0.50) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL29393782 0.85 LMNA (0.65) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL12457438 0.84 LMNA (0.42) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL4293397 0.83 LMNA (0.58) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL236696 0.83 LMNA (0.58) LMNAKDM4EDUSP3MEN1KMT2A
Succinic Acid SCHEMBL28660950 0.83 LMNA (0.58) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL26008132 0.83 KDM4E (0.58) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL14980032 0.83 KDM4E (0.50) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL26008127 0.83 LMNA (0.47) LMNAKDM4EDUSP3MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11090255-B2 Use of polycarboxylic acid compounds for the treatment of fibrious amino acid based substrates, especially hair MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2021-08-17 US disclosed
US-20200170923-A1 USE OF POLYCARBOXYLIC ACID COMPOUNDS FOR THE TREATMENT OF FIBRIOUS AMINO ACID BASED SUBSTRATES, ESPECIALLY HAIR MOMENTIVE PERFORMANCE MATERIALS INC. 2020-06-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11090255-B2 Use of polycarboxylic acid compounds for the treatment of fibrious amino acid based substrates, especially hair ABAT, PCCA, FH LMNA 2225/4885KDM4E 832/4885DUSP3 4556/4885
US-20200170923-A1 USE OF POLYCARBOXYLIC ACID COMPOUNDS FOR THE TREATMENT OF FIBRIOUS AMINO ACID BASED SUBSTRATES, ESPECIALLY HAIR ABAT, PCCA, FH LMNA 2225/4885KDM4E 832/4885DUSP3 4556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.